0.2400
0.0000
(0.00%)
At close: April 14 at 10:13:22 AM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Cash Flows from Used in Operating Activities Direct
-4,951.2120
-4,951.2120
-4,255.4560
-3,966.1500
Investing Cash Flow
-3.3550
-3.3550
-2.2440
-3.9240
Financing Cash Flow
--
--
--
21,361.1680
End Cash Position
16,441.0510
16,441.0510
21,396.4610
25,455.2890
Capital Expenditure
-3.3550
-3.3550
-2.2440
-3.9240
Issuance of Capital Stock
--
--
--
22,000.0060
Repurchase of Capital Stock
--
--
--
-638.8380
Free Cash Flow
-4,954.5670
-4,954.5670
-4,257.7000
-3,970.0740
6/30/2022 - 11/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
CMB.AX Cambium Bio Limited
0.3000
+7.14%